South China Morning Post · Jefferies

Hong Kong attracts wave of biotech IPO filings amid AI drug boom

· By Julie Zhang
Story summary

More than 10 pre-profit drug developers are seeking Hong Kong listings as AI-powered biotech platforms draw growing investor interest

Read at South China Morning Post

Opens the original publisher in a new tab. Full articles belong to their publishers; a subscription may be required.

Your local edition.

Choose a timezone for story timestamps and date filters.